June 18, 2018June 18, 2018

First Clinical Trial to Focus on Improving Hand Function in PPMS Patients Announced

News

A new clinical trial will be the first in the world to recognize the importance of retaining hand function for wheelchair-bound patients with primary progressive MS ... Read more

June 18, 2018June 18, 2018

MSAA Expands Financial Aid Fund for MRI Scans to Meet Growing Demand

News

The Multiple Sclerosis Association of America (MSAA) announced that it will expand its MRI Access Fund to help meet the growing demand for magnetic resonance imaging (MRI) tests ... Read more

June 15, 2018June 15, 2018

#EAN2018 – Ocrevus May Delay Progression to Wheelchair by Up to 7 Years, New Analysis of PPMS Patient Data Shows

News

Treatment with Ocrevus (ocrelizumab) slows disability progression in primary progressive multiple sclerosis (PPMS) in ways that may be of considerable importance to patients — including the ... Read more

June 15, 2018June 15, 2018

Discovery of ‘Fiery’ Cell Death Mechanism May Be MS ‘Game-Changer’

News

Researchers have unveiled a new cell death mechanism called pyroptosis — also known as “fiery death” — as a main factor driving neurodegeneration and loss of myelin ... Read more

June 14, 2018June 14, 2018

Obesity and Smoking in Teen Years Could Speed Adult’s Progression to SPMS, Study Reports

News

Young adults at age 20 who are obese and smoke are not only at a higher risk of developing relapsing multiple sclerosis — those who become ... Read more

June 14, 2018June 14, 2018

MyoPro Powered Arm Brace Now Available for Teens with MS or Injuries, Myomo Announces

News

Myomo, a wearable medical robotics company, announced that MyoPro — its myoelectric orthosis or powered brace — is now available for use by teenagers with paralyzed or weakened ... Read more

June 13, 2018June 13, 2018

Effectiveness of Gilenya and Tecfidera Compared in Real-World Study in Italy

News

Gilenya (fingolimod) and Tecfidera (dimethyl fumarate) are equally effective as first-line treatments in people with relapsing-remitting multiple sclerosis (RRMS), but Gilenya may be of slightly more benefit ... Read more

June 13, 2018June 13, 2018

MMJ Bioscience Files Request with FDA to Open Phase 2 Study of Medical Cannabis in Progressive MS

News

MMJ Bioscience, which specializes in medical cannabis products, has filed a request with the U.S. Food and Drug Administration (FDA) to open Phase 2 clinical trials ... Read more

June 12, 2018June 12, 2018

Gilenya Seen to Particularly Benefit Young Adults with Higher Relapse Rates, Trial Data Show

News

Young adults with multiple sclerosis (MS) have higher relapse rates and respond better to Gilenya treatment compared to the overall MS population, data from a post hoc ... Read more

June 12, 2018June 12, 2018

Perceptions of Fall Risk as Important as Physical Limitations and Need Be Part of Risk Assessment, Study Says

News

For ambulatory multiple sclerosis patients with mobility problems, perceptions of being at risk of falling are as important as the risk due to their physical condition ... Read more

June 11, 2018June 11, 2018

Vagus Nerve Signals Could Work as ‘Early Warning System’ for Inflammation in MS and Other Disease, Study Says

News

A new way of interpreting inflammatory signals using the vagus nerve — which carries such signals from throughout the body to the brain — has been ... Read more

June 11, 2018June 11, 2018

BIIB098 Showing Ability in Studies To Be Easier on GI Tract Than Tecfidera, Earning Alkermes $50M from Biogen

News

Alkermes announced that it has received a $50 million payment from Biogen after a review of preliminary data related to the gastrointestinal tolerability of BIIB098 (diroximel fumarate), now ... Read more

June 8, 2018June 8, 2018

Workplace Dress Codes Can Limit Opportunities for People with Disabilities, Researchers Say

News

Researchers at the University of Missouri found that a lack of appropriate clothing designed for people with disabilities, caused by accidents or chronic diseases like multiple sclerosis ... Read more

June 8, 2018June 8, 2018

Mobility Devices for People Who Have Lower-Limb Paralysis are Flawed, Online Survey Reveals

News

More investment and new technological developments are needed to assist people who have limited mobility because of lower-limb paralysis. That was the major conclusion of an ... Read more

June 7, 2018June 8, 2018

Atrophy of Brain Lesions Predicts Disability in MS, 10-year Study Finds

News

Atrophy (shrinkage) of brain lesions correlates with physical disability in patients with multiple sclerosis (MS), new research reports. The study, “Atrophied Brain Lesion Volume: A New ... Read more

June 7, 2018June 8, 2018

#CMSC2018 – Pharmacist Discusses Advances, Challenges in Cannabinoids Research to Treat MS

News

Several studies have demonstrated the therapeutic potential of cannabis and its derivate products to manage the symptoms of multiple sclerosis (MS) and other neurodegenerative diseases. But ... Read more

June 6, 2018June 6, 2018

#CMSC2018 — Inhibiting Oxidative Stress Enzyme Promotes Resealing of Blood-Brain Barrier in MS Mouse Model

News

Inhibiting an oxidative stress enzyme called myeloperoxidase protects the blood-brain barrier in a mouse model of multiple sclerosis (MS), limiting the migration of immune cells and ... Read more

June 6, 2018June 6, 2018

Canada Trails US in Patient Access to Rare Disease Therapies, CORD President Says

News

Canada’s healthcare system is excellent for people with common ailments like diabetes or high blood pressure, but it’s “basically failing the nearly three million Canadians with ... Read more